TORONTO, ONTARIO--(Marketwired - Jan. 13, 2015) - Canadian Cannabis Corp. ("CCAN" or the "Company") (OTCQB:CCAN) is pleased to announce the appointment of Mr. Richard Wachsberg to the Board of Directors. Richard is co-founder and Chairman of Apollo Health and Beauty Care, the leading Private Label and Control Label Personal Care Manufacturer in Canada with distribution throughout North and South America, Mexico, Europe, and Asia. Apollo Health and Beauty Care has been awarded the distinction of being one of Canada's 50 Best Managed Companies from 2003 to 2013 and has earned 50 Best Managed Company Platinum status since 2010.

Apollo Health and Beauty Care is engaged in the business of manufacturing and distribution of beauty care products and non-prescription drug products. Richard is actively involved in stewarding and supporting health care and primary care efforts in the Canadian health care industry and is further invested in same through his charitable endeavors.

"We look forward to working with Richard to expand our future leadership position in the progressive discovery of health benefits for patients and practical applications for patients in the use of Medical Marijuana and correlated products. We welcome Richard's experience in support of corporate governance of the Company, furthered by his belief in the health care contribution potential of Canadian Cannabis as an early stage investor." said Benjamin Ward - CEO.

Cautionary Note Regarding Forward-Looking Statements

Safe Harbor:

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when used in the preceding discussion, the words "pleased," "plan," "confident that," "believe," "expect," or "intend to," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Such risks and uncertainties include, but are not limited to, market conditions, competitive factors, the ability to successfully complete additional financings and other risks described in the Company's SEC reports and filings.